Adjustable Transobturator Male System (ATOMS) in Artificial Urinary Sphincter patients - a good Alternative?

{"INTRODUCTION:":[0],"Post-prostatectomy":[1],"stress":[2],"urinary":[3,15],"incontinence":[4,90],"(SUI)":[5],"significantly":[6],"impairs":[7],"patients'":[8],"quality":[9],"of":[10,29,45,63,123,155,168,173],"life.":[11],"While":[12],"the":[13,20,42,61,185,189],"artificial":[14],"sphincter":[16],"(AUS)":[17],"is":[18,31],"considered":[19],"gold":[21],"standard":[22],"for":[23,34,60,79,86,166,209],"managing":[24],"severe":[25,212],"SUI,":[26,81],"a":[27,171,203],"subset":[28],"patients":[30,46,74,124,169,210],"not":[32],"suitable":[33],"this":[35,67],"intervention.":[36],"This":[37],"study":[38],"aimed":[39],"to":[40,58,136,188,219,228],"evaluate":[41],"clinical":[43],"outcomes":[44,97,226],"who":[47,75,214],"received":[48,76],"an":[49,56],"adjustable":[50],"transobturator":[51],"male":[52],"system":[53],"(ATOMS)":[54],"as":[55],"alternative":[57,208],"AUS":[59,87,221],"treatment":[62,207],"SUI.":[64],"METHODS:":[65],"In":[66],"single-center":[68],"retrospective":[69],"study,":[70],"we":[71],"included":[72,98],"25":[73],"ATOMS":[77,201],"implantation":[78],"post-prostatectomy":[80],"despite":[82],"being":[83],"technically":[84],"eligible":[85],"based":[88],"on":[89],"severity":[91],"and":[92,104,147,181,205,232],"pelvic":[93,127],"floor":[94],"status.":[95],"Primary":[96],"pad":[99,131,151],"usage,":[100],"continence":[101,140,225],"rates,":[102],"complications,":[103],"patient-reported":[105],"satisfaction.":[106],"A":[107],"cross-sectional":[108],"follow-up":[109,162],"was":[110,119,133,143,178],"conducted":[111],"in":[112,145,150,153,239],"using":[113],"standardized":[114],"questionnaires.":[115],"RESULTS:":[116],"Median":[117],"age":[118],"74.0":[120],"years;":[121],"60%":[122,167],"had":[125],"undergone":[126],"radiotherapy.":[128],"Preoperative":[129],"median":[130,172],"usage":[132,152],"6.0/day,":[134],"reduced":[135],"3.0/day":[137],"postoperatively.":[138],"Social":[139],"(≤1":[141],"pad/day)":[142],"achieved":[144],"16%,":[146],"≥50%":[148],"reduction":[149],"76%":[154],"patients.":[156,242],"Complications":[157],"were":[158,164],"mostly":[159],"minor.":[160],"Cross-sectional":[161],"data":[163],"available":[165],"at":[170],"42":[174],"months.":[175],"Patient":[176],"satisfaction":[177,231],"high":[179,230],"(73.3%),":[180],"80%":[182],"would":[183],"recommend":[184],"procedure.":[186],"According":[187],"PGI":[190],"score,":[191],"73.3%":[192],"reported":[193],"\\"very":[194],"much\\"":[195],"or":[196,217],"\\"much":[197],"improved\\"":[198],"outcomes.":[199],"CONCLUSION:":[200],"represents":[202],"feasible":[204],"safe":[206],"with":[211],"SUI":[213],"are":[215],"unable":[216],"unwilling":[218],"undergo":[220],"implantation.":[222],"Despite":[223],"suboptimal":[224],"compared":[227],"AUS,":[229],"acceptable":[233],"complication":[234],"rates":[235],"support":[236],"its":[237],"use":[238],"appropriately":[240],"selected":[241]}